My Pancreatic Cancer has recurred. How does this change my treatment choices, and are new targeted therapies using...
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Pancreatic Cancer — the same guidelines oncologists use.
- Developed under the medical oversight of OpenCancer’s physician-scientist team (Chris Apfel, MD/PhD/MBA, CMO · Kaumudi Bhawe, PhD, CSO).
- Last updated October 15, 2025. Informational only — not a substitute for your oncology team.
Question asked:
My Pancreatic Cancer has recurred. How does this change my treatment choices, and are new targeted therapies using biomarkers (KRAS, BRCA1/2) available?
According to the NCCN Guidelines (2023), treatment options for recurrent pancreatic cancer depend on several factors:
- Previous Treatment History:
- If you previously had surgery, chemotherapy options may be recommended
- The location and extent of recurrence affects treatment choices
- Your overall health and ability to tolerate treatment is considered
- Biomarker Testing: The NCCN Guidelines strongly recommend comprehensive biomarker testing for all pancreatic cancer patients, specifically for:
- BRCA1/2 mutations
- KRAS mutations
- MSI/MMR status
- NTRK fusions
According to ASCO Guidelines (2023), targeted treatment options include:
- For BRCA1/2 mutations: PARP inhibitors like olaparib (FDA-approved)
- For MSI-High tumors: Immunotherapy options
- For NTRK fusion-positive cases: Targeted therapies like larotrectinib
The National Cancer Institute (NCI) emphasizes that treatment choices should be individualized based on:
- Location of recurrence
- Previous treatments received
- Molecular testing results
- Overall performance status
Important recommendations:
- Discuss comprehensive molecular testing with your oncologist if not already done
- Ask about clinical trial opportunities, as new targeted therapies are being studied
- Work with your healthcare team to develop a personalized treatment plan
Always remember that these decisions should be made in consultation with your healthcare team, who can evaluate your specific situation and medical history.
Would you like me to explain more about any of these treatment options or biomarker testing?
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Pancreatic Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Pancreatic Cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →